Skip Navigation

Cancer Genomics Shared Resource

Published Research

Citation Reference Language for Use of Shared Resource

Example citation: “The Cancer Genomics Shared Resource services are supported by the Comprehensive Cancer Center of Wake Forest Baptist Medical Center, NCI CCSG P30CA012197 grant.”


Program Key: CPC = Cancer Prevention and Control Program; CRP = Clinical Research Program; TPR = Tumor Progression and Recurrence Program; CBB = Cancer Biology and Biochemistry Program
  1. Levine EA(CRP), Votanopoulos KI, Qasem SA(CRP), Philip J, Cummins KA, Chou JA, Ruiz J(CRP), D’Agostino R(CPC), Shen P, and Miller LD(TPR). Prognostic molecular subtypes of low-grade cancer of the appendix. J Am Coll Surg. (in press)
  2. Chen X, Liu L, Mims J, Punska EC, Williams KE, Zhao W, Arcaro KF, Tsang AW(TPR), Zhou X(TPR), Furdui CM(CBB). Analysis of DNA Methylation and gene expression in radiation-resistant head and neck tumors. Epigenetics. 2015;10(6): 545-61. PMC4663186.
  3. Holmes JA, Paulsson AK, Page BR, Miller LD(TPR), Liu W, Xu J, Hinson WH, Lesser GJ(CRP), Tatter SB(CRP), Debinski W(TPR), Chan MD(CRP). Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. J Neurooncol. 2015;124: 447-53. PMC4584190.
  4. Maglic D, Stovall DB, Cline M(TPR), Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G(TPR), Inoue K(TPR). DMP1beta, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer. J Pathol. 2015;236(1): 90-102. PMC4398631.
  5. Cowherd S, Miller LD(TPR), Melin SA, Akman S(CRP), Isom S, Cole J, Pullikuth A, Lawrence JA(CRP). A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer. Cancer Biol Ther. 2015;16(5): 678-83. PMC4622683.
  6. Pardee TS(CRP), Lee K, Luddy J, Maturo C, Rodriguez RJ, Isom S, Miller LD(TPR), Ellis LR, Levitan D, Hurd D(CRP), Powell BL(CRP). A Phase I study of the first-in-class anti-mitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies. Clin Cancer Res. 2014;20(20): 5255-64. PMC4199870.
  7. Alistar A(CRP), Chou JW, Nagalla S, Black MA, D'Agostino R, Jr.(CPC), Miller LD(TPR). Dual roles for immune metagenes in breast cancer prognosis and therapy prediction. Genome Med. 2014;6(10): 80. PMC4240891.
  8. Paulsson AK, Holmes JA, Peiffer AM(CRP), Miller LD(TPR), Liu W(CPC), Xu J(CPC), Hinson WH, Lesser GJ(CRP), Tatter SB(CRP), Debinski W(TPR), Chan MD(CRP). Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2): 429-35. PMC4146694.
  9. Blackham AU, Northrup SA, Willingham M, Sirintrapun J, Russell GB, Lyles DS(TPR), Stewart JH 4th(TPR). Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. J Surg Res. 2014;187(2):412-26. PMC3959227.
  10. Moore ED, Kooshki M, Wheeler KT, Metheny-Barlow LJ(TPR), Robbins ME(CBB). Differential expression of Homer1a in the hippocampus and cortex likely plays a role in radiation-induced brain injury. Radiation Res. 2014;181(1):21-32. PMC4118588.
  11. Stovall DB, Wan M, Miller LD(TPR), Cao P, Maglic D, Zhang Q, Stampfer MR, Liu W(CPC), Xu J(CPC), Sui G(TPR). The Regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013;183(5): 1645-53. PMC3814686.
  12. Nagalla S, Chou JW, Willingham MC, Ruiz J(CRP), Vaughn JP, Dubey P(TPR), Lash TL(CPC), Hamilton-Dutoit, Bergh J, Sotiriou C, Miller LD(TPR). Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol. 2013;14(4): R34. PMC3798758.
  13. Liu W(CPC), Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Koty PP, Kader AK, Cramer SD(CBB), Bova GS, Zheng SL, Grönberg H, Isaacs WB, Xu J(CPC). Genetic markers associated with early cancer-specific mortality following prostatectomy. Cancer. 2013;119(13):2405-12. PMC3863778.
  14. Aryee MJ, Liu W(CPC), Engelmann JC, Nuhn P, Gurel M, Haffner MC, Esopi D, Irizarry RA, Getzenberg RH, Nelson WG, Luo J, Xu J(CPC), Isaacs WB, Bova GS, Yegnasubramanian S. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5(169):169ra10. PMC3577373.
  15. Rajani KR, Pettit Kneller EL, McKenzie MO, Horita DA, Chou JW, Lyles DS(TPR). Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription. PLoS Pathog. 2012;8(9):e1002929. PMC3460625.
  16. Kim JW, Kim S-T, Turner AR, Young T, Smith S, Liu W(CPC), Lindberg J, Egevad L, Gronberg H, Isaacs WB, Xu J(CPC). Identification of new differentially methylated genes that have potential functional consequences in prostate cancer. PLoS One. 2012;7(10):e48455. PMC3485209.
  17. Wan M, Huang W, Kute TE, Miller LD(TPR), Zhang Q, Hatcher H, Wang J, Stovall DB, Russell GB, Cao PD, Deng Z, Wang W, Zhang Q, Lei M, Torti SV(CBB), Akman SA(CRP), Sui G(TPR). Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. Am J Pathol. 2012;180(5):2120-33. PMC3828504.


Quick Reference

Cancer Genomics Shared Resource
Lance D. Miller, PhD


Gregory Hawkins, PhD


Technical Staff
Lou Craddock


Wei Cui


Jamie Haywood


Dr. Jeff Chou


Hanes 4026/4028
NRC 311/312
Find A Doctor Ways to Give
Last Updated: 08-05-2016
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.